ImmunityBio Inc
Research facility
Location:
Santa Cruz,
United States (USA) (US)
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy (2021)
Reimann H, Nguyen A, Sanborn JZ, Vaske CJ, Benz SC, Niazi K, Rabizadeh S, et al.
Journal article
BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC) (2021)
Vladimirova V, Schneeweiss A, Jackisch C, Weber KE, Denkert C, Schmatloch S, Karn T, et al.
Conference contribution